GSSG is then converted back to its reduced form by glutathione reductase (GR) in the presence of NAPDH, which is converted into NADP+
In normal physiology, glutathione participates in redox reactions and is involved in Phase II liver metabolic pathways, both of which are well documented in the biochemical literature
In preclinical work, BPC-157 has been evaluated in cell-based and animal models, in which investigators examine tissue integrity, barrier function, and responses to experimentally induced stress or injury under controlled conditions
Researchers are responsible for compliance with all applicable institutional, state, and federal regulations
During the design phase, we also consider plasma protein compatibility and in vivo degradation pathways to ensure efficient drug release in target tissues, improving therapeutic outcomes while reducing systemic toxicity risk